Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of metal-organic ligand framework ZIF-67 modified hollow vanadium dioxide core-membrane composite structure drug carrier

A ZIF-67, organic ligand technology, applied in the field of biomaterials and regenerative medicine, can solve the problems of loss of dryness, easy aging, and low quantity, and achieve the effect of improving therapeutic effect, promoting proliferation and increasing efficiency

Active Publication Date: 2022-03-18
ZHEJIANG UNIV
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Stem cells have great prospects in the field of cell therapy, but they have the disadvantages of small number during application, easy aging and loss of stemness, and lack of specific signals for directional differentiation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of metal-organic ligand framework ZIF-67 modified hollow vanadium dioxide core-membrane composite structure drug carrier
  • Application of metal-organic ligand framework ZIF-67 modified hollow vanadium dioxide core-membrane composite structure drug carrier
  • Application of metal-organic ligand framework ZIF-67 modified hollow vanadium dioxide core-membrane composite structure drug carrier

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Example 1 Construction of a hollow vanadium dioxide core-membrane composite structure drug carrier modified by the metal-organic ligand framework ZIF-67

[0039] Will 1.82g V 2 o 5 Dissolve in 450mL1.6mol / L oxalic acid solution, and stir the mixed solution at room temperature until the solution becomes a khaki suspension. The obtained suspension was placed in a polytetrafluoroethylene reactor for hydrothermal reaction, and kept at 180° C. for 36 hours. Naturally cool to normal temperature after the reaction and collect the blue-black precipitate VO 2 Dry in a constant temperature ventilated drying oven at 60°C.

[0040] Take out 100mg of the prepared VO 2 Disperse evenly in 200mL of methanol solution, add 3g of cobalt nitrate hexahydrate, stir evenly, add 300mL of 0.2g / mL 2-methylimidazole in methanol solution, stir at room temperature for more than 24 hours, make it fully react, and prepare the sample Centrifugal washing with deionized water and ethanol, and vacuu...

Embodiment 2

[0042] Example 2 Construction of a hollow vanadium dioxide core-membrane composite structure drug carrier modified by the metal-organic ligand framework ZIF-67

[0043] Will 1.82g V 2 o 5 Dissolve in 500mL1.2mol / L oxalic acid solution, and stir the mixed solution at room temperature until the solution becomes a khaki suspension. The obtained suspension was placed in a polytetrafluoroethylene reactor for hydrothermal reaction, and kept at 300° C. for 28 hours. Naturally cool to normal temperature after the reaction and collect the blue-black precipitate VO 2 Dry in a constant temperature ventilated drying oven at 60°C.

[0044] Take out 100mg of the prepared VO 2 Disperse evenly in 300mL of methanol solution, add 5g of cobalt nitrate hexahydrate, stir evenly, add 500mL of 0.15g / mL 2-methylimidazole in methanol solution, stir at room temperature for more than 24 hours, make it fully react, and prepare the sample Centrifugal washing with deionized water and ethanol, and vacu...

Embodiment 3

[0045] Example 3 VO 2 Determination of specific surface area and pore diameter of @ZIF-67 core-membrane composite drug carrier

[0046] Take out the VO that embodiment 1,2 makes 2 , placed in an oven at 60°C for 1 to 2 hours, then cooled to room temperature, cleaned and dried the empty sample tube, and degassed the empty sample tube at 120°C for 1 hour. Add the dried sample into the empty sample tube, then degas the sample under vacuum at 150°C for 2 hours, then cool to room temperature. Transfer the degassed sample to the analysis station for low-temperature nitrogen adsorption, use a Dewar bottle filled with liquid nitrogen to test the sample at a constant temperature, and then use the sample as the adsorbent, high-purity nitrogen as the adsorbate and high-purity helium as the The carrier is subjected to isothermal adsorption and desorption at the temperature of 77.3K liquid nitrogen and the relative pressure point of nitrogen in the range of 0.048 to 0.996. The nitrogen a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Specific surface areaaaaaaaaaaa
Specific surface areaaaaaaaaaaa
Pore diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses an application of a hollow vanadium dioxide core-membrane composite structure drug carrier modified by a metal-organic ligand framework ZIF-67. The drug carrier with the composite structure can carry different drugs at the same time, the content of the carried drugs is high, and the functions of programmed regulation and inhibition of stem cell aging, promotion of stem cell proliferation and induction of stem cell neural differentiation and nerve excitation are achieved. Compared with single nano VO2, the nano VO2 has more excellent drug loading capacity and lower cytotoxicity, effectively improves the treatment effect of stem cells, and can be applied to in-situ tissue regeneration. According to the carrier, ginsenoside Rg1 is coated in a hollow core of the drug carrier, ligustroside is adsorbed on an outer layer membrane of the drug carrier, programmed release is achieved, stem cells are induced to differentiate to nerves, and the nerve excitation function effect of the stem cells is more remarkable.

Description

technical field [0001] The invention belongs to the field of biomaterials and regenerative medicine, and in particular relates to the application of a hollow vanadium dioxide core-membrane composite structure drug carrier modified by a metal-organic ligand framework ZIF-67. Background technique [0002] Stem cells have the ability to self-renew and differentiate, and can differentiate into other cells, tissues and organs. Given the unique regenerative capacity of stem cells, stem cell therapy has great potential in the treatment of a variety of diseases. The body can achieve cell renewal through the proliferation and differentiation of autologous stem cells; however, the number of stem cells in various tissues and organs will gradually decrease with age, and the ability to proliferate and differentiate will also decline, so damaged tissues and organs cannot be repaired in time. In situ tissue engineering technology, also known as in situ induced regeneration technology, ref...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/52A61K47/02A61K31/7048A61K31/704A61K47/69A61P25/00A61P39/06B82Y5/00B82Y30/00B82Y40/00C08G83/00
CPCA61K9/5115A61K9/5192A61K31/7048A61K31/704A61K47/6949A61P25/00A61P39/06B82Y5/00B82Y30/00B82Y40/00C08G83/008A61K2300/00
Inventor 彭丽华袁铁军黄奕谕
Owner ZHEJIANG UNIV